Brainstorm Cell Therapeutics  logo
Brainstorm Cell Therapeutics BCLI
€ 1.10 -1.27%

Quartalsbericht 2024-Q2
hinzugefügt 14.08.2024

report update icon

Brainstorm Cell Therapeutics Kennzahlen 2011-2024 | BCLI

Kennzahlen Jährlich Brainstorm Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.9 -2.8 -5.9 -5.9 -3.8 -5.3 -13.7 -10.3 -5.4 -5.9 -8.9 -9.2 -6.7

P/S

- - - - - - - - - - - - -

EPS

-0.4 -0.7 -0.7 -1.1 -1.1 -0.7 - - - - - - -

EV (Enterprise Value)

39.6 M 77.5 M 136 M 166 M 106 M 78.9 M 70.7 M 51.6 M 48 M 53.5 M 42 M 31.7 M 25.8 M

EBITDA per Share

-0.49 -0.67 -0.67 -1.01 -1.04 -0.698 -0.262 -0.268 -0.464 -0.543 -0.467 -0.384 -0.467

EV/EBITDA

-5.6 -4.8 -3.8 -5.2 -13.3 -10.1 -5.3 -6.8 -8.0 -8.6 -6.5

PEG

0.65 -0.08 -0.17 0.16 0.07 0.03 -3.69 -0.25 -0.17 0.12 0.18 -0.28 2.32

P/B

-6.6 -22.2 7.5 5.3 -7.2 14.7 11.5 5.2 3.2 8.2 15.9 7.9 17.8

P/CF

-1.6 -3.5 -5.5 -5.3 -7.5 -5.8 -26.6 -8.6 -6.1 -11.7 -10.4 -10.5 -11.6

ROE %

353.89 805.21 -126.45 -89.70 190.24 -278.07 -84.22 -50.31 -60.08 -138.52 -178.86 -86.14 -263.31

ROA %

-408.56 -287.27 -83.54 -62.06 -355.88 -124.23 -43.35 -46.28 -49.70 -93.29 -103.66 -64.60 -142.78

ROCE %

596.85 7112.32 -106.88 -79.16 206.84 -280.36 -85.02 -51.33 -60.42 -109.16 -147.85 -84.34 -242.01

Current Ratio

0.5 0.7 2.9 3.8 0.2 1.7 1.7 12.1 5.7 3.1 3.3 4.3 2.0

DSO

- - - - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Brainstorm Cell Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.04 -0.05 - -0.03 -0.13 -0.14 - -0.19 -0.19 -0.15 - -0.15 -0.17 -0.19 - -0.14 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

-0.04 -0.04 - -0.13 -0.14 -0.14 - -0.19 -0.21 -0.15 - -0.14 -0.17 -0.19 - -0.14 -0.25 -0.29 - -0.25 -0.22 -0.23 - -0.15 -0.16 -0.12 - -0.13 -0.06 -0.09 - -0.09 -0.05 -0.1 - -0.14 -0.13 -0.12 - -0.16 -0.1 -0.18 - -0.1 -0.01 -0.01 - -0.01 -0.01 -0.01 - -0.01 0.01 0.01

ROE %

228.29 293.52 289.28 -204.81 -746.39 -973.34 -620.77 -642.18 -169.50 -100.59 -60.59 -73.24 -64.49 -64.56 -56.38 -10.29 48.46 259.55 426.57 148.50 -175.66 -643.97 -834.21 -918.43 -724.58 -530.72 -252.65 -302.97 -269.06 -235.16 -150.94 -211.02 -220.78 -230.55 -180.24 -318.75 -397.19 -475.63 -415.55 -594.41 -634.76 -675.10 -536.58 -622.72 -530.00 -437.27 -258.41 -521.72 -698.89 -876.06 -789.92 -263.31 -263.31 -263.31

ROA %

-189.45 -237.46 -178.57 -230.31 -260.48 -204.89 -109.66 -125.11 -88.82 -66.52 -44.01 -52.76 -46.07 -45.65 -39.01 -125.24 -202.71 -544.16 -797.98 -922.20 -960.20 -728.55 -372.68 -416.03 -335.15 -254.28 -130.05 -176.33 -179.25 -182.18 -138.83 -188.52 -191.94 -195.36 -149.09 -242.38 -285.97 -329.57 -279.87 -383.53 -393.90 -404.27 -310.98 -375.58 -336.51 -297.45 -193.79 -336.57 -414.76 -492.95 -428.35 -142.78 -142.78 -142.78

ROCE %

2108.43 2240.22 1426.74 1267.87 164.56 -184.04 -256.89 -275.28 -134.80 -84.42 -53.46 -64.67 -57.48 -58.06 -50.45 -0.53 60.59 122.76 137.91 73.48 -40.87 -146.09 -171.97 -212.65 -188.90 -145.64 -89.06 -105.61 -81.47 -73.11 -44.77 -62.97 -64.62 -71.42 -50.53 -86.28 -103.82 -106.13 -85.83 -117.68 -113.79 -138.95 -107.93 -136.81 -133.84 -110.46 -71.50 -118.14 -135.90 -41.69 74.13 -46.64 73.39 47.38

Current Ratio

0.6 0.4 0.5 0.7 0.6 0.6 0.7 1.1 1.7 2.3 3.0 3.6 3.5 3.9 3.2 3.2 3.2 3.2 0.3 0.3 0.3 0.3 1.8 1.8 1.8 1.8 2.1 2.1 2.1 2.1 12.5 - - - 5.8 6.0 6.8 6.3 3.1 3.1 3.1 3.1 2.4 2.4 2.4 2.4 4.4 4.0 4.0 4.0 2.2 2.2 2.2 2.2

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung